Treating ARDS: New hope for a tough problem

The Lancet Respiratory Medicine

Volumn 2, Issue 2, 2014, Pages 84-85

  Gotts, Jeffrey E ^a   Matthay, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5'-NUCLEOTIDASE; ADJUVANTS, IMMUNOLOGIC; FEMALE; HUMANS; INTERFERON-BETA; LUNG; MALE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84895073387     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70285-6     Document Type: Note

References (12)

1. Matthay MA, Ware LB, Zimmerman GA The acute respiratory distress syndrome. J Clin Invest 2012, 122:2731-2740.
2. Bellingan G, Maksimow M, Howell D, et al. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study. Lancet Respir Med 2013, published online Dec 23. http://dx.doi.org/10.1016/S2213-2600(13)70259-5.
3. Panitch HS, Hirsch RL, Haley AS, Johnson KP Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987, 329:893-895.
4. McGraw CA, Lublin FD Interferon beta and glatiramer acetate therapy. Neurother J Am Soc Exp Neurother 2013, 10:2-18.
5. González-Navajas JM, Lee J, David M, Raz E Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012, 12:125-135.
6. Niemelä J, Ifergan I, Yegutkin GG, Jalkanen S, Prat A, Airas L IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. Eur J Immunol 2008, 38:2718-2726.
7. Deaglio S, Robson SC Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol San Diego Calif 2011, 61:301-332.
8. Kiss J, Yegutkin GG, Koskinen K, Savunen T, Jalkanen S, Salmi M IFN-beta protects from vascular leakage via up-regulation of CD73. Eur J Immunol 2007, 37:3334-3338.
9. Cobelens PM, Tiebosch IACW, Dijkhuizen RM, et al. Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage. Crit Care Lond Engl 2010, 14:R157.
10. Eckle T, Füllbier L, Wehrmann M, et al. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 2007, 178:8127-8137.
11. Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009, 119:1910-1920.
12. Zhou Y, Murthy JN, Zeng D, Belardinelli L, Blackburn MR Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. PloS One 2010, 5:e9224.